A New Possible Indication of Direct-acting Anti-hepatitis C Drugs in the Therapeutic Management of COVID-19: A Narrative Literature Review

Alireza Mashhadi Hemmatabadi ¹ , Fatemeh Jafari ¹ , Hesamoddin Hosseinjani ¹ *

Cited by CrossRef: 1

1- Shajari R, Mohammadbeigi A, Ahmadpour S, Shakeri M, Adeli S, Vafaeimanesh J, Tabaraii R, Hosseini S, Asghari A. EVALUATION OF THE EFFICACY OF RECIGEN AND REMDESIVIR DRUGS IN THE TREATMENT OF COVID-19 OUTPATIENTS: A COMPARATIVE STUDY IN QOM CITY, IRAN. Studies in Medical Sciences. 2024;35(3):238 [Crossref]

Submit Your Paper Editorial Board Instructions for Authors Instructions for Reviewers Contact Us Editorial Policies Peer Review Archive

Indexing & Abstracting:

Follow us on LinkedIn
Follow us on Twitter

Director-in-Charge:
Prof. Khosro Adibkia

Editor-in-Chief:
Prof. Ali Shayanfar

Follower of ICMJE